Page 49 - Genentech News Today

Alan Aldrich passed away. This is the full obituary where you can share condolences and memories. Published in the Record Eagle on 2024-01-28.

Tisch Cancer Institute researchers discovered that a certain type of chemotherapy improves the immune system's ability to fight off bladder cancer, particularly when combined with immunotherapy, according to a study published in Cell Reports Medicine in January.

Tisch Cancer Institute researchers discovered that a certain type of chemotherapy improves the immune system’s ability to fight off bladder cancer, particular

(RTTNews) - Genentech, a member of the Roche Group (RHHBY), said that new long-term data for the companys Vabysmo showed sustained retinal drying...

Olaparib plus abiraterone acetate delayed disease progression and improved outcomes in patients with BRCA-, ATM- and CDK12-mutated mCRPC.

On January 10, 2024, the United States Patent and Trademark Office (USPTO) issued "Guidelines for Assessing Enablement in Utility Applications...

Compared to TACE alone, durvalumab plus TACE and bevacizumab reduced the risk of disease progression or death by 23%; however, further research is needed to assess OS.

/PRNewswire/ -- The surge in colposcopy device demand is mainly driven by a growing incidence of cervical disorders like cervical cancer and inflammatory...

Here are three technology stocks enjoying strong long-term growth that will make you wealthy when you retire.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!